Clinical and bacteriological evaluation of a twice daily regimen of epicillin capsules for the treatment of skin infections.
Fifty-five patients with impetigo, ecthyma, or folliculitis caused by epicillin-sensitive strains of Streptococcus pyogenes or Staphylococcus aureus were treated with 500 mg epicillin capsules twice daily for an average duration of 9 days. Bacteriological and clinical examinations were performed at 2-day intervals. Favourable clinical responses (excellent or good) were obtained in 95% of the patients. No side effects were observed.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D002648:Child; D004473:Ecthyma / Q000188:drug therapy*; D005260:Female; D005499:Folliculitis / Q000188:drug therapy*; D006801:Humans; D007169:Impetigo / Q000188:drug therapy*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D013211:Staphylococcus aureus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects
D000667:Ampicillin